Peer Review reports
From: High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma
| Original Submission | ||
|---|---|---|
| 29 Sep 2021 | Submitted | Original manuscript |
| 7 Oct 2021 | Reviewed | Reviewer Report |
| 13 Nov 2021 | Reviewed | Reviewer Report |
| 28 Nov 2021 | Author responded | Author comments - Jun Du |
| Resubmission - Version 2 | ||
| 28 Nov 2021 | Submitted | Manuscript version 2 |
| 4 Dec 2021 | Author responded | Author comments - Jun Du |
| Resubmission - Version 3 | ||
| 4 Dec 2021 | Submitted | Manuscript version 3 |
| 28 Dec 2021 | Reviewed | Reviewer Report |
| 3 Jan 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 4 Jan 2022 | Editorially accepted | |
| 18 Jan 2022 | Article published | 10.1186/s12885-022-09180-5 |
You can find further information about peer review here.